Navigation Links
Hospira Supports Disaster Relief Efforts in Haiti With Products and Cash Grants
Date:1/23/2010

LAKE FOREST, Ill., Jan. 22 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, and its philanthropic arm, the Hospira Foundation, have made initial donations of approximately $1.75 million in medical products and cash grants to support humanitarian relief efforts in Haiti. More than 750,000 units of Hospira products, valued at more than $1.5 million, are either in Haiti or en route to the country and include antibiotics, intravenous (I.V.) solutions, analgesics and anesthetics, all of which are in high demand and are integral to serving the needs of disaster victims.

"We are working closely with humanitarian aid agencies to help the people of Haiti obtain access to critical products needed in the provision of medical care," said Christopher B. Begley, chairman and chief executive officer. "The Hospira family expresses deep sympathy to all of the victims of this tragedy, and we will continue to work in the coming weeks and months to provide health and wellness to this devastated region."

In addition to donating products, Hospira has made a total of $200,000 in initial cash grants to the Red Cross and to the company's partners, which include AmeriCares, Direct Relief International, Catholic Medical Mission Board (CMMB) and Project Hope. Hospira also will match employee contributions dollar for dollar up to $50,000 through the Hospira Foundation.

Hospira will continue to monitor disaster relief efforts in Haiti, and will evaluate opportunities to provide additional assistance as further needs and information become available.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at www.hospira.com.

SOURCE Hospira, Inc.

RELATED LINKS
http://www.hospira.com

'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hospira to Present at J.P. Morgan 28th Annual Healthcare Conference Jan. 13, 2010
2. Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 Projections
3. Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers
4. Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings
5. Hospira Reports Third-Quarter 2009 Results
6. Hospira Names Daphne E. Jones Chief Information Officer
7. Hospira to Present at Credit Suisse 18th Annual Healthcare Conference Nov. 11
8. Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
9. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
10. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
11. PROXY Governance Recommends Against Taros Board and Supports Sun
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... , May 26, 2016 ... market growth is the emergence of new treatments. Cardax, ... therapies for osteoarthritis treatment. The therapy is expected to ... Arthritis Research UK is conducting studies to develop new ... study, where the genes involved in osteoarthritis are being ...
(Date:5/26/2016)... , May 26, 2016   ... software and analytics, network solutions and technology-enabled ... announced it entered into a strategic channel ... of outpatient software solutions and revenue cycle ... specialty hospitals and rehabilitation clinics to optimize ...
(Date:5/25/2016)... -- FDA 510(k) clearance covers Confocal ... urological and surgical applications Mauna Kea ... the multidisciplinary confocal laser endomicroscopy (CLE) platform, today ... with the 12 th 510(k) clearance from ... new FDA clearance covers Confocal Miniprobes indicated for ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... ... A book about the self-discovery of one’s limitless creative power, “ Unleash Your ... give readers the courage they need to embrace their creativity and unleash it as ... my life to learn and create what I set my heart with no limits ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... "ProDrop 3D ... projects to the next level," said Christina Austin - CEO of Pixel Film Studios. ... Studios. With ProDrop 3D Abstract have the ability to generate and manipulate three-dimensional shapes ...
(Date:5/31/2016)... ... ... According to recent statistics, there are nearly half a million physical therapists ... physical therapy professional and every clinic has a duty to perform at the highest ... competitive industry is also essential. The solution that many physical therapy leaders turn to ...
(Date:5/31/2016)... (PRWEB) , ... June 01, 2016 , ... ... “ Psoriasis and smoking: links and risks ”. , As corresponding author Professor ... on the relation between smoking habits and psoriasis. Smoking influences the onset and ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... that considers individuals’ genetic characteristics and the physical and behavioral worlds in ... in sync. In personalized medicine, diagnosing an individual’s disease depends on accurately ...
Breaking Medicine News(10 mins):